Patents by Inventor James Hildreth

James Hildreth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11926846
    Abstract: A method of enhancing sperm fertility is described herein. The method includes contacting sperm with hydroxyurea. A composition is disclosed that includes sperm, hydroxyurea, and a buffer. Methods, kits, and compositions for enhancing sperm fertility are also provided.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: March 12, 2024
    Assignee: Meharry Medical College
    Inventors: Anthony Archibong, James Hildreth, Letitia Lyons, Shannon Roberson
  • Publication number: 20200087619
    Abstract: A method of enhancing sperm fertility is described herein. The method includes contacting sperm with hydroxyurea. A composition is disclosed that includes sperm, hydroxyurea, and a buffer. Methods, kits, and compositions for enhancing sperm fertility are also provided.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 19, 2020
    Inventors: Anthony Archibong, James Hildreth, Letitia Lyons, Shannon Roberson
  • Publication number: 20070255080
    Abstract: An improvement in a process for the production of ethylbenzene from a dilute ethylene stream wherein an ethylene-containing stream derived from a cracking process is directed to an ethylene fractionator for separation of ethylene and ethane. The improvement includes providing the dilute ethylene stream by liquefying and separating out a portion of the ethylene-containing stream prior to directing the remainder of the ethylene-containing stream to the ethylene fractionator and/or by drawing off a side stream from the ethylene fractionator; and, directing the dilute ethylene stream as a feed to an alkylator for alkylation with benzene to produce ethylbenzene.
    Type: Application
    Filed: July 6, 2007
    Publication date: November 1, 2007
    Applicant: ABB Lummus Global Inc.
    Inventors: James Hildreth, Kerman Dukandar, Ronald Venner
  • Publication number: 20070173481
    Abstract: This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to prevent infection. The compositions of the invention can be used to reduce or prevent maternal to fetal transmission of a microorganism and/or to reduce or eliminate a microorganism present in a blood sample or a blood product.
    Type: Application
    Filed: December 11, 2006
    Publication date: July 26, 2007
    Inventors: George Scheele, James Hildreth
  • Publication number: 20070088000
    Abstract: Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a ?-cyclodextrin are provided. Methods for reducing the risk of transmission of a sexually transmitted pathogen to or from a subject by contacting the pathogen or cells susceptible to the pathogen in the subject with a pharmaceutical composition containing a ?-cyclodextrin also are provided. Accordingly, pharmaceutical compositions, which include 1) a ?-cyclodextrin, which is in an amount that blocks passage of the pathogen through lipid rafts in the membrane of a cell susceptible to the pathogen, and 2) a contraceptive, an agent for treating a sexually transmitted disease, a lubricant, or a combination thereof, are provided, as are composition formulated from a solid substrate that contains an amount of ?-cyclodextrin useful for reducing the risk of transmission of a sexually transmitted pathogen.
    Type: Application
    Filed: November 27, 2006
    Publication date: April 19, 2007
    Inventor: James Hildreth
  • Publication number: 20060205824
    Abstract: The invention provides enantiomers of ajoene and derivatives of Z(?)-ajoene. The derivative of Z(?)-ajoene are useful for modulating integrin-mediated functions, for treating disorders, diseases or conditions in which integrins play a role, and for treating tissues to improve their condition for a subsequent use, such as transplantation.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Inventors: John Davidson, Alexander Tatarintsev, Ali Turgiev, James Hildreth
  • Publication number: 20060004036
    Abstract: The present invention relates to sigma-2 receptor agonists and their use in the treatment of immunodeficiency virus infections, especially human immunodeficiency virus (HIV) infections. The invention particularly relates to sigma-2 agonists, especially CB-184 and its analogues, that decrease cellular production of sphingomyelin when provided to recipient cells, and inhibit HIV replication.
    Type: Application
    Filed: July 15, 2005
    Publication date: January 5, 2006
    Applicant: The United States of America, per Secy. DHHS, NIH
    Inventors: Wayne Bowen, Keith Crawford, James Hildreth
  • Publication number: 20050215522
    Abstract: Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a ?-cyclodextrin are provided. Methods for reducing the risk of transmission of a sexually transmitted pathogen to or from a subject by contacting the pathogen or cells susceptible to the pathogen in the subject with a pharmaceutical composition containing a ?-cyclodextrin also are provided. Accordingly, pharmaceutical compositions, which include 1) a ?-cyclodextrin, which is in an amount that blocks passage of the pathogen through lipid rafts in the membrane of a cell susceptible to the pathogen, and 2) a contraceptive, an agent for treating a sexually transmitted disease, a lubricant, or a combination thereof, are provided, as are composition formulated from a solid substrate that contains an amount of ?-cyclodextrin useful for reducing the risk of transmission of a sexually transmitted pathogen.
    Type: Application
    Filed: December 28, 2004
    Publication date: September 29, 2005
    Inventor: James Hildreth
  • Publication number: 20050158315
    Abstract: Monoclonal antibodies and method for ameliorating an immune response disorder. The monoclonal antibodies are specific for an epitope present on the leukocyte adhesion receptor ?-chain.
    Type: Application
    Filed: January 12, 2005
    Publication date: July 21, 2005
    Inventor: James Hildreth
  • Publication number: 20050054888
    Abstract: An improvement in a process for the production of ethylbenzene from a dilute ethylene stream wherein an ethylene-containing stream derived from a cracking process is directed to an ethylene fractionator for separation of ethylene and ethane. The improvement includes providing the dilute ethylene stream by liquefying and separating out a portion of the ethylene-containing stream prior to directing the remainder of the ethylene-containing stream to the ethylene fractionator and/or by drawing off a side stream from the ethylene fractionator; and, directing the dilute ethylene stream as a feed to an alkylator for alkylation with benzene to produce ethylbenzene.
    Type: Application
    Filed: September 8, 2003
    Publication date: March 10, 2005
    Inventors: James Hildreth, Kerman Dukandar, Ronald Venner
  • Publication number: 20050015847
    Abstract: This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to prevent infection. The compositions of the invention can be used to decontaminate skin and environmental surfaces that are contacted with microorganisms such as envelope viruses.
    Type: Application
    Filed: August 8, 2003
    Publication date: January 27, 2005
    Inventors: George Scheele, James Hildreth